Blueprint Medicines expands oncology portfolio by acquiring Lengo Therapeutics for US$465 million by Editor | Dec 1, 2021 | Hospitals, LATEST NEWS, Mergers, Investments & Funding, WORLD NEWS | 0 USA – Blueprint Medicines, a US-based biotech that specializes in targeted cancer drugs, is... Read More